Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Cell Res ; 383(1): 111497, 2019 10 01.
Article in English | MEDLINE | ID: mdl-31301291

ABSTRACT

TGF-ß-activated kinase 1 (TAK1) plays a pivotal role in Toll-like receptor (TLR) signaling pathway. However, the mechanisms controlling its activity remain poorly understood. Here, we show that leucine-rich repeat containing 62 (LRRC62), a previously uncharacterized protein, negatively regulates TLR signaling by targeting TAK1. Expression of LRRC62 inhibits the TLRs-induced production of pro-inflammatory cytokine, whereas deficiency in LRRC62 enhances the activation of NF-κB and MAPK signaling and increases the production of pro-inflammatory cytokines. Mechanically, LRRC62 functions as an adaptor to recruit deubiquitinase CYLD to TAK1, thus inhibits the K63-linked poly-ubiquitination and activation of TAK1. Together, our findings uncover an unrecognized mechanism by which LRRC62 antagonizes the activation of TAK1 in a CYLD-mediated deubiquitination-dependent manner, thereby balancing Toll-like receptor signaling to avert overzealous inflammation.


Subject(s)
Deubiquitinating Enzyme CYLD/metabolism , MAP Kinase Kinase Kinases/metabolism , Membrane Proteins/metabolism , NF-kappa B/metabolism , Toll-Like Receptors/metabolism , Ubiquitination , Deubiquitinating Enzyme CYLD/genetics , HEK293 Cells , Humans , MAP Kinase Kinase Kinases/genetics , Membrane Proteins/genetics , NF-kappa B/genetics , Protein Binding , Proteolysis , Signal Transduction , Toll-Like Receptors/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...